Background: Spontaneous Coronary Artery Dissection (SCAD) is an uncommon presentation of acute coronary syndrome. Awareness of this condition has grown over recent years. The optimal management and prognosis remains unknown.
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Method: We reviewed hospital records of all patients with angiographically confirmed SCAD in Christchurch since August 2011.
Results: 103 SCAD patients (86% female, median age 54) presented with NSTEMI (63%), STEMI (29%), cardiac arrest (5%), angina (2%) or stroke (1%). The commonest culprit was the LAD (44%), with left main involved in 1% and multiple vessels in 5%. Initial management was conservative in 83% and percutaneous coronary intervention (PCI) in 17%, with 67% procedural success. 83% of patients were prescribed dual-anti-platelets, including 94% of those with PCI. Beta-blockers were prescribed in 76%. Further in-hospital myocardial infarct (MI) occurred in 5% of patients with unplanned revascularization in 3% (including CABG in 2%). Over median follow-up of 1.8 years, 16% of patients had recurrent MI, including 9% with complications of the index event, and 7% recurrent SCAD in a different vessel (median 2.5 years since index presentation). There was a trend towards increased in-hospital MI, unplanned revascularisation and recurrent MI in those treated with PCI however this was not statistically significant (p-value 0.21, 0.08 and 0.47 respectively). 3 patients died, one by intracranial haemorrhage during index presentation and the others non-cardiac.
Conclusion: The majority of our SCAD cohort were managed conservatively with relatively few major in-hospital adverse events. However, recurrent SCAD is not rare and further research is needed to identify those at highest risk. 
Austin Health, Heidelberg, Australia
Background: Studies have found that elderly patients are less likely to undergo evidence-based management and coro-nary angiography compared to younger patients. Given that older patients are more likely have multiple-comorbidities, they are often underrepresented in trials and studies. Hence, there is a lack of applicability and evidence in this population group.
Methods: Computerised literature searches from MED-LINE and EMBASE were used to identify studies evaluating the impact of management on outcomes of elderly patients (≥75 years) with NSTEMI. Pre-specified outcomes assessed included primary outcome (major adverse cardiovascular events MACE), mortality rate and risk of major bleeding. Intervention and effect on specified outcomes were assessed.
Results: We reviewed 5 randomised controlled trials (RCTs) and 2 observational studies comparing medical therapy (conservative) vs angiography with revascularisation if indicated (invasive) treatment in elderly populations with NSTEMI. 6 out of 7 of the studies showed that invasive treatment had improved primary outcomes. In terms of mortality rate, the 5 RCTs showed no statistical difference between the 2 groups while the 2 observational studies showed reduced mortality rates with patients who had invasive treatment. While the rates of major bleeding were generally low in both groups, 4 of the 7 studies still showed an increase risk in the invasive group.
Conclusion: Invasive treatment of NSTEMI in the elderly has generally been shown to improve primary outcomes of patients. However, this may come at the expense of an increased risk of major bleeding. Hence, further studies are necessary to fully evaluate the risk vs benefits. 
The Prince Charles Hospital, Brisbane, Australia
Background: Obtaining accurate annular and coronary height measurements are vital in peri-procedural TAVI decision making and TAVI outcomes. Pre-operative planning software allows operators to analyse cardiac CT data in 3dimension to ensure accurate assessment. We have noted a degree of operator variability when measuring aortic annular area as well as coronary heights with this software.
Methods: We retrospectively analysed 34 patients at our centre who underwent TAVI in whom measurements were obtained from both a TAVI operator (Group 1) as well as an experienced radiographer (Group 2). Each group had previously analysed over 100 TAVI's. We further analysed whether the valve size decision changed following a second measurement using <430 mm 2 , 431 mm 2 -540 mm 2 and >541 mm 2 as valve sizing cut-offs.
Results: There was no significant difference in the measurement of annulus areas (457 ± 93 VS 439 ± 96, p = 0.43), left coronary ostia heights (13.4 ± 3.3 VS 12.8 ± 3.4, p = 0.8) or right coronary ostia heights (16.2 ± 3.5 VS 15.9 ± 3.3, p = 0.7). However, there were five instances where the valve size decision was changed following a second measurement which crossed one of the cut-offs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
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Conclusion:
In our retrospective observational study of TAVI measurement variability, we found that there was no significant difference in the measurement variability of annular area or coronary heights between TAVI operators or our experienced radiographers. However, clinical decision making was altered on five occasions with changes in valve sizing due to minor measurement variability. 
